CHARM THERAPEUTICS
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
CHARM THERAPEUTICS
Industry:
Artificial Intelligence Biotechnology
Founded:
2021-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.charmtx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
50 M USD
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
NanoTemper Technologies
NanoTemper builds tools for challenging characterizations: affinity screening, molecular interactions, protein stability, or protein quality
Current Advisors List
Current Employees Featured
Founder
Investors List
Braavos Capital
Braavos Capital investment in Series A - CHARM Therapeutics
Axial VC
Axial VC investment in Series A - CHARM Therapeutics
General Catalyst
General Catalyst investment in Series A - CHARM Therapeutics
Khosla Ventures
Khosla Ventures investment in Series A - CHARM Therapeutics
F-Prime Capital
F-Prime Capital investment in Series A - CHARM Therapeutics
OrbiMed
OrbiMed investment in Series A - CHARM Therapeutics
Official Site Inspections
http://www.charmtx.com Semrush global rank: 4.7 M Semrush visits lastest month: 2.04 K
- Host name: 25.26.205.92.host.secureserver.net
- IP address: 92.205.26.25
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
More informations about "CHARM Therapeutics"
About - CHARM Therapeutics
We are an entrepreneurial team of extraordinary scientists, engineers and entrepreneurs, purpose-built to meld cutting edge know-how from 3D deep learning and drug discovery.See details»
Careers - CHARM Therapeutics
Founded by leaders with a track record in next-wave AI with a culture of excellence and innovation at its heart we are committed to delivering transformational medicines to patients …See details»
CHARM Therapeutics - Crunchbase Company Profile
Contact Email [email protected] CHARM Therapeutics delivers transformational medicines through 3D deep learning and cutting-edge drug discovery technologies. It delivers transformational medicines through 3D …See details»
CHARM Therapeutics - LinkedIn
CHARM Therapeutics | 9,658 followers on LinkedIn. Harnessing the power of deep learning to deliver therapeutics of transformational efficacy for patients. | CHARM Therapeutics is discovering and ...See details»
CHARM Therapeutics - VentureRadar
Similar Companies: Biorce Spain Privately Held Biorce is a TechBio company leveraging artificial intelligence to enhance clinical trial processes. Their proprietary AI model, Jarvis, centralizes …See details»
CHARM Therapeutics Bolsters Leadership Team with Key …
Dec 12, 2023 Contacts. Laksh Aithani, Chief Executive Officer CHARM Therapeutics Phone: +44 7933 185425 Email: [email protected] Consilium Strategic Communications Amber …See details»
CHARM Therapeutics Receives Investment for Deep
May 15, 2023 The investment enables CHARM to continue to fund its rapidly growing organization while harnessing the power of NVIDIA's accelerated computing platform. ...See details»
CHARM Therapeutics Bolsters Leadership Team with Key …
Dec 12, 2023 For more information, please visit: www.charmtx.com. For further information, please contact: Laksh Aithani, Chief Executive Officer CHARM Therapeutics Phone: +44 7933 …See details»
Meet 'CHARM Therapeutics', a London-Based Startup …
Jun 16, 2022 Drug design based on the structure has considerably impacted drug discovery, but some constraints have limited its potential. The most common target for drugs is proteins. And in order to achieve an effect, one must first …See details»
CHARM Therapeutics Receives Investment for Deep
May 15, 2023 LONDON--(BUSINESS WIRE)--CHARM Therapeutics (“CHARM”), a 3D deep-learning biotechnology company discovering and developing transformational medicines, today announced an investment from ...See details»
CHARM Therapeutics launches with a $50 million Series A
Jun 9, 2022 [email protected]. Consilium Strategic Communications. Amber Fennell/Chris Gardner/Jessica Hodgson. Phone: 44 (0)20 3709 5700. [email protected] . …See details»
CHARM Therapeutics Announces Collaboration with Bristol Myers …
Mar 20, 2023 For more information, please visit: www.charmtx.com. Contacts. Media Madeline Davidshofer MacDougall Advisors +1 (781) 235-3060 [email protected]. Release …See details»
CHARM Therapeutics Strengthens Leadership Team with Key
Jan 4, 2023 [email protected]. Consilium Strategic Communications. Amber Fennell /Jessica Hodgson / Chris Gardner. Phone: 44 (0)20 3709 5700. [email protected]. About …See details»
CHARM Therapeutics Receives Investment for Deep Learning …
May 15, 2023 Investment enables CHARM to continue to fund its rapidly growing organization while harnessing the power of NVIDIA’s accelerated computing platform LONDON, United …See details»
CHARM Therapeutics Strengthens Leadership Team with Key …
Jan 4, 2023 PRESS RELEASE CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery and Development Capability Enhanced leadership …See details»
Recommended Stories - Yahoo Finance
Jun 9, 2022 PRESS RELEASE CHARM Therapeutics launches with a $50 million Series A financing to transform structure-based drug discovery using its proprietary DragonFold AI …See details»
Charm Therapeutics Company Information - Funding, Investors, …
Insights. Charm Therapeutics shows promise by combining deep learning with 3D molecular structures to develop treatments for harmful proteins. This method offers a significant …See details»
Laksh Aithani - CHARM Therapeutics
Apr 30, 2024 Laksh started his entrepreneurship journey during University, co-founding Genei, an AI company, which has since gone through Y-Combinator and raised a seed round from …See details»
CHARM Therapeutics Strengthens Leadership Team with Key …
Jan 4, 2023 [email protected]. Consilium Strategic Communications. Amber Fennell /Jessica Hodgson / Chris Gardner. Phone: 44 (0)20 3709 5700. [email protected]. About …See details»